Prestige Consumer Healthcare Inc. buy BMO Capital Markets
Start price
15.11.23
/
50%
€53.50
Target price
15.11.24
€107.78
Performance (%)
21.50%
Price
27.08.24
€65.00
Summary
This prediction is currently active. The BUY prediction by BMO_Capital_Markets currently has a performance of 21.50%. This prediction currently runs until 15.11.24. The prediction end date can be changed by BMO_Capital_Markets at any time. BMO_Capital_Markets has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m |
---|---|---|
Prestige Consumer Healthcare Inc. | 4.065% | 4.065% |
iShares Core DAX® | 1.937% | 1.473% |
iShares Nasdaq 100 | -1.186% | -0.040% |
iShares Nikkei 225® | 1.938% | 4.205% |
iShares S&P 500 | -0.023% | 0.109% |
Comments by BMO_Capital_Markets for this prediction
In the thread Prestige Consumer Healthcare Inc. diskutieren
Prestige Consumer Healthcare Inc. (NYSE: PBH) had its price target lowered by analysts at BMO Capital Markets from $124.00 to $117.00. They now have an "outperform" rating on the stock.
Ratings data for PBH provided by MarketBeat